234 related articles for article (PubMed ID: 28866363)
1. Effects of apolipoprotein M in uremic atherosclerosis.
Bosteen MH; Madsen Svarrer EM; Bisgaard LS; Martinussen T; Madsen M; Nielsen LB; Christoffersen C; Pedersen TX
Atherosclerosis; 2017 Oct; 265():93-101. PubMed ID: 28866363
[TBL] [Abstract][Full Text] [Related]
2. Plasma levels of sphingosine-1-phosphate and apolipoprotein M in patients with monogenic disorders of HDL metabolism.
Karuna R; Park R; Othman A; Holleboom AG; Motazacker MM; Sutter I; Kuivenhoven JA; Rohrer L; Matile H; Hornemann T; Stoffel M; Rentsch KM; von Eckardstein A
Atherosclerosis; 2011 Dec; 219(2):855-63. PubMed ID: 21944699
[TBL] [Abstract][Full Text] [Related]
3. LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine 1-phosphate.
Kurano M; Tsukamoto K; Hara M; Ohkawa R; Ikeda H; Yatomi Y
J Biol Chem; 2015 Jan; 290(4):2477-88. PubMed ID: 25505264
[TBL] [Abstract][Full Text] [Related]
4. Elevating Endogenous Sphingosine-1-Phosphate (S1P) Levels Improves Endothelial Function and Ameliorates Atherosclerosis in Low Density Lipoprotein Receptor-Deficient (LDL-R-/-) Mice.
Feuerborn R; Besser M; Potì F; Burkhardt R; Weißen-Plenz G; Ceglarek U; Simoni M; Proia RL; Freise H; Nofer JR
Thromb Haemost; 2018 Aug; 118(8):1470-1480. PubMed ID: 30060257
[TBL] [Abstract][Full Text] [Related]
5. Dihydro-sphingosine 1-phosphate interacts with carrier proteins in a manner distinct from that of sphingosine 1-phosphate.
Mishima Y; Kurano M; Kobayashi T; Nishikawa M; Ohkawa R; Tozuka M; Yatomi Y
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30279204
[TBL] [Abstract][Full Text] [Related]
6. Involvement of CETP (Cholesteryl Ester Transfer Protein) in the Shift of Sphingosine-1-Phosphate Among Lipoproteins and in the Modulation of its Functions.
Kurano M; Hara M; Ikeda H; Tsukamoto K; Yatomi Y
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):506-514. PubMed ID: 28126827
[TBL] [Abstract][Full Text] [Related]
7. Effect of menopause and exercise training on plasma apolipoprotein M and sphingosine-1-phosphate.
Yafasova A; Mandrup CM; Egelund J; Nyberg M; Stallknecht B; Hellsten Y; Nielsen LB; Christoffersen C
J Appl Physiol (1985); 2019 Jan; 126(1):214-220. PubMed ID: 30433864
[TBL] [Abstract][Full Text] [Related]
8. Sphingosine 1-Phosphate and Atherosclerosis.
Kurano M; Yatomi Y
J Atheroscler Thromb; 2018 Jan; 25(1):16-26. PubMed ID: 28724841
[TBL] [Abstract][Full Text] [Related]
9. Liver involvement in sphingosine 1-phosphate dynamism revealed by adenoviral hepatic overexpression of apolipoprotein M.
Kurano M; Tsukamoto K; Ohkawa R; Hara M; Iino J; Kageyama Y; Ikeda H; Yatomi Y
Atherosclerosis; 2013 Jul; 229(1):102-9. PubMed ID: 23664237
[TBL] [Abstract][Full Text] [Related]
10. Plasma apoM and S1P levels are inversely associated with mortality in African Americans with type 2 diabetes mellitus.
Liu M; Frej C; Langefeld CD; Divers J; Bowden DW; Carr JJ; Gebre AK; Xu J; Larsson B; Dahlbäck B; Freedman BI; Parks JS
J Lipid Res; 2019 Aug; 60(8):1425-1431. PubMed ID: 31133557
[TBL] [Abstract][Full Text] [Related]
11. Hepatic apolipoprotein M (apoM) overexpression stimulates formation of larger apoM/sphingosine 1-phosphate-enriched plasma high density lipoprotein.
Liu M; Seo J; Allegood J; Bi X; Zhu X; Boudyguina E; Gebre AK; Avni D; Shah D; Sorci-Thomas MG; Thomas MJ; Shelness GS; Spiegel S; Parks JS
J Biol Chem; 2014 Jan; 289(5):2801-14. PubMed ID: 24318881
[TBL] [Abstract][Full Text] [Related]
12. Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice.
Obinata H; Kuo A; Wada Y; Swendeman S; Liu CH; Blaho VA; Nagumo R; Satoh K; Izumi T; Hla T
J Lipid Res; 2019 Nov; 60(11):1912-1921. PubMed ID: 31462513
[TBL] [Abstract][Full Text] [Related]
13. Vehicle-dependent Effects of Sphingosine 1-phosphate on Plasminogen Activator Inhibitor-1 Expression.
Takahashi C; Kurano M; Nishikawa M; Kano K; Dohi T; Miyauchi K; Daida H; Shimizu T; Aoki J; Yatomi Y
J Atheroscler Thromb; 2017 Sep; 24(9):954-969. PubMed ID: 28321011
[TBL] [Abstract][Full Text] [Related]
14. High-Density Lipoprotein-Associated Apolipoprotein M Limits Endothelial Inflammation by Delivering Sphingosine-1-Phosphate to the Sphingosine-1-Phosphate Receptor 1.
Ruiz M; Frej C; Holmér A; Guo LJ; Tran S; Dahlbäck B
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):118-129. PubMed ID: 27879252
[TBL] [Abstract][Full Text] [Related]
15. Uremia modulates the phenotype of aortic smooth muscle cells.
Madsen M; Aarup A; Albinsson S; Hartvigsen K; Sørensen CM; Turczynska K; Nielsen LB; Pedersen TX
Atherosclerosis; 2017 Feb; 257():64-70. PubMed ID: 28107707
[TBL] [Abstract][Full Text] [Related]
16. [The role of apolipoprotein M and sphingosine 1-phosphate axis in the prevention of atherosclerosis].
Nádró B; Juhász L; Szentpéteri A; Páll D; Paragh G; Harangi M
Orv Hetil; 2018 Feb; 159(5):168-175. PubMed ID: 29376427
[TBL] [Abstract][Full Text] [Related]
17. Signaling of Serum Amyloid A Through Receptor for Advanced Glycation End Products as a Possible Mechanism for Uremia-Related Atherosclerosis.
Belmokhtar K; Robert T; Ortillon J; Braconnier A; Vuiblet V; Boulagnon-Rombi C; Diebold MD; Pietrement C; Schmidt AM; Rieu P; Touré F
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):800-9. PubMed ID: 26988587
[TBL] [Abstract][Full Text] [Related]
18. Uncleaved ApoM signal peptide is required for formation of large ApoM/sphingosine 1-phosphate (S1P)-enriched HDL particles.
Liu M; Allegood J; Zhu X; Seo J; Gebre AK; Boudyguina E; Cheng D; Chuang CC; Shelness GS; Spiegel S; Parks JS
J Biol Chem; 2015 Mar; 290(12):7861-70. PubMed ID: 25627684
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein M and Sphingosine-1-Phosphate Receptor 1 Promote the Transendothelial Transport of High-Density Lipoprotein.
Velagapudi S; Rohrer L; Poti F; Feuerborn R; Perisa D; Wang D; Panteloglou G; Potapenko A; Yalcinkaya M; Hülsmeier AJ; Hesse B; Lukasz A; Liu M; Parks JS; Christoffersen C; Stoffel M; Simoni M; Nofer JR; von Eckardstein A
Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):e468-e479. PubMed ID: 34407633
[TBL] [Abstract][Full Text] [Related]
20. A Shift in ApoM/S1P Between HDL-Particles in Women With Type 1 Diabetes Mellitus Is Associated With Impaired Anti-Inflammatory Effects of the ApoM/S1P Complex.
Frej C; Mendez AJ; Ruiz M; Castillo M; Hughes TA; Dahlbäck B; Goldberg RB
Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1194-1205. PubMed ID: 28385702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
